Adipokines and the Risk of Reflux Esophagitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Seoul National University Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Donghee Kim, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01560598
First received: March 20, 2012
Last updated: March 21, 2012
Last verified: March 2012

March 20, 2012
March 21, 2012
June 2012
June 2013   (final data collection date for primary outcome measure)
Difference in serum adipokine levels between case and control groups [ Time Frame: 2 month lager (after sampling) ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01560598 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Adipokines and the Risk of Reflux Esophagitis
Adipokines and the Risk of Reflux Esophagitis : Prospective Case-control Study

We aimed to risk faoctors for GERD and association between visceral obesity, plasma adipoline(leptin, adiponectin, IL-6, TNF-α)and development of reflux esophagitis in healthy Koreans.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

serum

Non-Probability Sample

healthy adults who visit healthcare system for routine checkup

  • Visceral Obesity
  • Reflux Esophagitis
Not Provided
  • Reflux esophagitis
    those with endoscopically proven reflux esophagitis
  • Normal
    those with normal GFS finding (without definite mucosal break at Z-line)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
600
Not Provided
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • endoscopically proven reflux esophagitis

Exclusion Criteria:

  • those with esophageal hiatal hernia, current PPI medication, upper GI operation history
Both
18 Years to 75 Years
Yes
Contact: Kyung-Sang Yu, Professor +82-2-2072-1920 ksyu@snu.ac.kr
Contact: Jeong-Hwa Hong, IRB analyst +82-2-740-8096 jhhong@snu.ac.kr
Korea, Republic of
 
NCT01560598
gerdadipokine
Yes
Donghee Kim, Seoul National University Hospital
Seoul National University Hospital
Not Provided
Not Provided
Seoul National University Hospital
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP